Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-4 of 4
Keywords: Therapy failure
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Cyrielle Coignion, Mathilde Poli, Sharmila Sagnier, Geneviève Freyburger, Pauline Renou, Sabrina Debruxelles, François Rouanet, Igor Sibon
Journal:
European Neurology
Eur Neurol (2015) 74 (3-4): 135–139.
Published Online: 15 September 2015
... Antiplatelet drug Stroke Stroke causes Therapy failure Previous studies have reported that 30-40% of the patients admitted for an ischemic stroke are taking aspirin or another antiplatelet drug (APD) at admission [ 1 ]. This APD treatment failure can be related to many causes from inobservance...
Journal Articles
Subject Area:
Neurology and Neuroscience
Journal:
European Neurology
Eur Neurol (2002) 48 (1): 26–29.
Published Online: 11 July 2002
...Dirk Dressler In some patients treated with botulinum toxin type A (BT), secondary therapy failure occurs. It can either be partial (PSTF) or complete (CSTF). One of the main causes for CSTF is the formation of antibodies against BT. We wanted to study the clinical features of BT antibody-induced...
Journal Articles
Subject Area:
Neurology and Neuroscience
Journal:
European Neurology
Eur Neurol (2002) 47 (2): 118–121.
Published Online: 15 February 2002
...Dirk Dressler; Alexander Münchau; Kailash P. Bhatia; Niall P. Quinn; Hans Bigalke In some patients treated with botulinum toxin type A (BT) therapy failure occurs due to the formation of antibodies against BT (BT-AB). We investigated whether increased BT doses can overcome this form of therapy...
Journal Articles
Subject Area:
Neurology and Neuroscience
Journal:
European Neurology
Eur Neurol (2001) 45 (4): 257–260.
Published Online: 18 May 2001
... samples from patients with cervical dystonia and complete or partial BT therapy failure underwent blinded simultaneous IPA and MDA testing. 27 (82%) samples showed concordant results, 17 (52%) being positive and 10 (30%) negative for both IPA and MDA resulting in a significant association...